BioSpace News Archive

Hidradenitis Suppurativa Market Research Report on Growth, Recent Trends and Demand by Top Key Vendors till 2030

Forecast to 2030,’ thoroughly examines the Hidradenitis Suppurativa industry to provide essential data & information for the targeted readers.

July 25, 2022
·
5 min read
Mastocytosis Market Report on Rising Demand, Future Scope and Regional Forecast by 2030

Forecast to 2030,’ thoroughly examines the Mastocytosis industry to provide essential data & information for the targeted readers.

July 25, 2022
·
5 min read
Supraventricular Tachycardia Treatment Market Research on Present and Future Growth Prospects by 2030

Forecast to 2030,’ thoroughly examines the Supraventricular Tachycardia Treatment industry to provide essential data & information for the targeted readers.

July 25, 2022
·
5 min read
Transverse Myelitis Market Analysis on New Growth Startegies with Upcoming Trends and Forecast to 2030

Forecast to 2030,’ thoroughly examines the Transverse Myelitis industry to provide essential data & information for the targeted readers.

July 25, 2022
·
5 min read
Lone Star Bio

Berkshire Biomedical Awarded NIH Research Grant to Support Continued Development of the COPA™ System for Automated at Home Methadone Administration

Berkshire Biomedical Corporation (“Berkshire” or “the Company”), today announced that it has been awarded the first phase of a two-phase Fast-Track Small Business Innovation Research (SBIR) grant (1R44DA057185-01) from the National Institutes of Health’s (NIH) National Institute of Drug Abuse (NIDA).

July 25, 2022
·
5 min read
Business

Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2022 Financial Results

Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), today announced that the Company will host a conference call and live audio webcast on Wednesday, August 3, 2022 at 5:00 PM ET to report its second quarter 2022 financial results and provide a corporate update.

July 25, 2022
·
1 min read
Business

Allakos Announces the Appointment of Dr. Amy Ladd to its Board of Directors

Allakos Inc. (the “Company”) (Nasdaq: ALLK), today announced the appointment of Amy L. Ladd, M.D., orthopaedic surgeon and professor at Stanford University, to the Allakos board of directors.

July 25, 2022
·
5 min read
Business

ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2022 financial results on Monday, August 8, 2022, prior to market open.

July 25, 2022
·
1 min read
Business

Tabula Rasa HealthCare Schedules Second Quarter 2022 Earnings Conference Call

Tabula Rasa HealthCare, Inc.® (NASDAQ: TRHC), will hold a conference call and webcast to discuss its second quarter 2022 operating results Friday, August 5, 2022 at 8:30 a.m. EDT.

July 25, 2022
·
1 min read
Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform

Rona Therapeutics, Inc announced that it has obtained worldwide exclusive rights to Sanofi’s siRNA platform of chemical modification and delivery moiety as well as rights to four pre-clinical candidates for undisclosed targets.

July 25, 2022
·
2 min read